Insights into Aptamer–Drug Delivery Systems against Prostate Cancer
Prostate cancer is a common cancer in elderly males. Significant progress has been made in the drug therapies for prostate cancer in recent years. However, side effects are still problems that have not been overcome by the currently used anti-prostate cancer drugs. Novel technologies can be applied...
Main Authors: | Xueni Wang, Qian Zhou, Xiaoning Li, Xia Gan, Peng Liu, Xiaotao Feng, Gang Fang, Yonghong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/11/3446 |
Similar Items
-
Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
by: Taurean Brown, et al.
Published: (2021-02-01) -
Albumin is a reliable drug-delivering molecule: Highlighting points in cancer therapy
by: Akmal M. Asrorov, et al.
Published: (2024-06-01) -
Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms
by: Muhammad A. Alsherbiny, et al.
Published: (2021-09-01) -
Effect of taxanes on the miR-106 and miR-200c expression in prostate cancer cells in vivo and in vitro
by: D. S. Plevako, et al.
Published: (2023-01-01) -
STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel
by: Sandra M. Rocha, et al.
Published: (2023-04-01)